NASDAQ:BCPCBalchem Stock Price, Forecast & News

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BCPC stock has increased by 15.2% and is now trading at $102.83.
View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Balchem.

Balchem is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings results on Friday, July, 31st. The basic materials company reported $0.85 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.55 by $0.30. The basic materials company had revenue of $173.36 million for the quarter, compared to analyst estimates of $161.35 million. Balchem had a return on equity of 14.32% and a net margin of 12.18%. Balchem's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 earnings per share.
View Balchem's earnings history.

Balchem declared an annual dividend on Wednesday, December 18th. Stockholders of record on Monday, December 30th will be paid a dividend of $0.52 per share on Friday, January 17th. This represents a dividend yield of 0.51%. The ex-dividend date is Friday, December 27th. This is a boost from Balchem's previous annual dividend of $0.47.
View Balchem's dividend history.

2 analysts have issued 12-month target prices for Balchem's shares. Their forecasts range from $100.00 to $126.00. On average, they anticipate Balchem's share price to reach $113.00 in the next year. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for Balchem.

News headlines about BCPC stock have trended neutral this week, according to InfoTrie. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Balchem earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media coverage about the basic materials company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.
View the latest news about Balchem.

Balchem saw a decrease in short interest in July. As of July 31st, there was short interest totaling 433,300 shares, a decrease of 12.4% from the July 15th total of 494,500 shares. Based on an average daily trading volume, of 167,300 shares, the short-interest ratio is presently 2.6 days. Currently, 1.4% of the shares of the stock are sold short.
View Balchem's Short Interest.

Some companies that are related to Balchem include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), PolyOne (POL), Sensient Technologies (SXT) and Innospec (IOSP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), IBM (IBM), NVIDIA (NVDA), AbbVie (ABBV), Costco Wholesale (COST), CVS Health (CVS), Lowe's Companies (LOW), AT&T (T), Adobe (ADBE) and Cisco Systems (CSCO).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by many different retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (2.75%), GW&K Investment Management LLC (1.12%), New York State Common Retirement Fund (0.96%), Principal Financial Group Inc. (0.76%), Tributary Capital Management LLC (0.68%) and Assenagon Asset Management S.A. (0.40%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, ProShare Advisors LLC, Moody Aldrich Partners LLC, Principal Financial Group Inc., PNC Financial Services Group Inc., SG Americas Securities LLC, Brinker Capital Inc., and Bath Savings Trust Co.
View insider buying and selling activity for Balchem.

BCPC stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Conestoga Capital Advisors LLC, GW&K Investment Management LLC, First Trust Advisors LP, Tributary Capital Management LLC, Raymond James & Associates, Swiss National Bank, and Cutter & CO Brokerage Inc.. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason.
View insider buying and selling activity for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $102.83.

Balchem has a market capitalization of $3.33 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]